Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial

Autor: Stephen J. Thomas, John L. Perez, Stephen P. Lockhart, Subramanian Hariharan, Nicholas Kitchin, Ruth Bailey, Katherine Liau, Eleni Lagkadinou, Özlem Türeci, Ugur Şahin, Xia Xu, Kenneth Koury, Samuel S. Dychter, Claire Lu, Teresa C. Gentile, William C. Gruber

Publikováno v: Vaccine

Introduction Individuals with an underlying malignancy have high risk of poor COVID-19 outcomes. In clinical trials, COVID-19 vaccines were safe and efficacious against infection, hospitalization, and death, but most trials excluded participants with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cb5f1adc9988d2825bb0d5a9ad1defc
https://doi.org/10.1016/j.vaccine.2021.12.046

Clinical laboratory evaluation of COVID-19

Autor: Li Zhang, Shuomin Li, Zhufeng Chen, Wanju Xu, Ma Wanshan, Hao Mingju, Yuanxun Fang, Shi Xiaohong

Publikováno v: Clinica Chimica Acta; International Journal of Clinical Chemistry

COVID-19, caused by SARS-CoV-2, is a highly infectious disease, and clinical laboratory detection has played important roles in its diagnosis and in evaluating progression of the disease. Nucleic acid amplification testing or gene sequencing can serv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e01a08c176cdc8b4a0445df4480e07
https://doi.org/10.1016/j.cca.2021.04.022

Learning Health System in Crisis: Lessons From the COVID-19 Pandemic

Autor: Dorothy Hung, Sylvia Sudat, Dominick L. Frosch, Alice R. Pressman, Kristen M.J. Azar, Robert J. Romanelli

Publikováno v: Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 171-176 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic proceedings. Innovations, quality & outcomes, vol 5, iss 1

The novel coronavirus disease (COVID-19) pandemic is the gravest public-health crisis that the United States has seen in more than a century. Healthcare delivery systems are the focal point for interfacing with COVID-19; however, many were and remain

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f11e14f26c1734108800c918d48affd
https://doi.org/10.1016/j.mayocpiqo.2020.10.004

Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area

Autor: Kevin Grumbach, Yuteh Cheng, Ralph Gonzales, Alex Dahlen, George W. Rutherford, Jenna Bollyky, Sergio Garcia, Charles S. Craik, Timothy J. Judson, Derek B. Boothroyd, Manisha Desai, Hannah A. Sample, Haley Hedlin, Christina Lindan, Jeff Henne, Yingjie Weng, Yvonne Maldonado

Publikováno v: Annals of Epidemiology

Purpose We describe the design of a longitudinal cohort study to determine SARS-CoV-2 incidence and prevalence among a population-based sample of adults living in six San Francisco Bay Area counties. Methods Using an address-based sample, we stratifi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2f2ada0b53a4744b4570a70ed66d25
https://escholarship.org/uc/item/2v3351vw

Beyond Influenza Vaccination: Expanding Infrastructure for Hospital-based Pediatric COVID-19 Vaccine Delivery

Autor: Annika M. Hofstetter, Suchitra Rao, Ravi Jhaveri

Publikováno v: Clinical Therapeutics

Controlling the spread of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), will rely on vaccination at increasing rates and in an equitable manner. The main reasons for under-vac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f280b895e90db3aecf55c9cb1f19ff
https://pubmed.ncbi.nlm.nih.gov/35172946